Sign In
Buy AMGN
$338.22
+9.96 (+3.03%)
At Close: Jun 03, 2026
President Trump demands drugmakers slash prices within 60 days
06:54am, Friday, 01'st Aug 2025
CNBC's Joe Kernen reports on the latest news.
AMGEN ANNOUNCES WEBCAST OF 2025 SECOND QUARTER FINANCIAL RESULTS
04:01pm, Thursday, 31'st Jul 2025
THOUSAND OAKS, Calif. , July 31, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that it will report its second quarter 2025 financial results on Tuesday, August 5, 2025, after the close of
Trump pressures 17 pharma CEOs to cut US drug prices
02:28pm, Thursday, 31'st Jul 2025
U.S. President Donald Trump sent letters to the chief executives of 17 major pharmaceutical companies, urging immediate action to lower the cost of prescription drugs for Americans, the White House sa
Trump says he asked 17 drugmakers to take steps to cut U.S. prices within 60 days
01:48pm, Thursday, 31'st Jul 2025
President Donald Trump said he asked major pharmaceutical companies to take steps to cut U.S. drug prices within the next 60 days. It comes after Trump in May signed an executive order reviving a cont
Gear Up for Amgen (AMGN) Q2 Earnings: Wall Street Estimates for Key Metrics
10:16am, Thursday, 31'st Jul 2025
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Amgen (AMGN), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quart
Amgen Gears Up to Report Q2 Earnings: Will the Beat Streak Continue?
09:56am, Wednesday, 30'th Jul 2025
AMGN eyes another earnings beat as strong drug volumes offset pricing pressure and biosimilar headwinds.
Amgen (AMGN) Reports Next Week: Wall Street Expects Earnings Growth
11:05am, Tuesday, 29'th Jul 2025
Amgen (AMGN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Amgen (AMGN) Just Flashed Golden Cross Signal: Do You Buy?
10:56am, Tuesday, 29'th Jul 2025
Amgen Inc. (AMGN) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, AMGN's 50-day simple moving average broke out above its 200-day mo
Amgen (AMGN) Stock Falls Amid Market Uptick: What Investors Need to Know
06:51pm, Monday, 28'th Jul 2025
Amgen (AMGN) reached $301.29 at the closing of the latest trading day, reflecting a -1.73% change compared to its last close.
5 Dogs of the Dow Are Crushing the S&P 500 and Nasdaq in 2025
02:45pm, Monday, 28'th Jul 2025
The Dogs of the Dow is a well-known strategy first published in 1991 by Michael O'Higgins.
Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know
10:01am, Monday, 28'th Jul 2025
Amgen (AMGN) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Amgen vs. Novo Nordisk: Which Pharma Giant Is the Better Buy?
10:51am, Wednesday, 23'rd Jul 2025
AMGN's deep pipeline and rare disease expansion may outweigh NVO's GLP-1 dominance and leadership shakeup.
Dow Leads as Health Care Stocks Merck and Amgen Gain: Stock Market Today
04:07pm, Tuesday, 22'nd Jul 2025
Second-quarter earnings season remained top of mind Tuesday, with Coca-Cola and GM among those reporting.
NodThera Announces Appointment of Dr. Jyothis George as Chief Medical Officer
07:00am, Monday, 21'st Jul 2025
NodThera Announces Appointment of Dr. Jyothis George as Chief Medical Officer Former Amgen, Novo Nordisk and Boehringer Ingelheim senior leader joins NodThera Leadership Team Will spearhead clinical a
Amgen (AMGN) Declines More Than Market: Some Information for Investors
06:51pm, Friday, 18'th Jul 2025
In the latest trading session, Amgen (AMGN) closed at $294.76, marking a -1.17% move from the previous day.
